Deregulated PAX-5 transcription from a translocated IgH promoter in marginal zone lymphoma.

Abstract:

:The PAX-5 gene codes for the transcription factor BSAP, which is expressed throughout B-cell development. Although loss-of-function mutation in the mouse showed an essential role for Pax-5 in early B lymphopoiesis, gain-of-function mutations have implicated the human PAX-5 gene in the control of late B-cell differentiation. PAX-5 (on 9p13) has been involved together with the immunoglobulin heavy-chain (IgH) gene (on 14q32) in the recurring t(9;14)(p13;q32) translocation that is characteristic of small lymphocytic lymphoma with plasmacytoid differentiation. Here we have characterized a complex t(2;9;14)(p12;p13;q32) translocation present in a closely related non-Hodgkin's lymphoma referred to as splenic marginal zone lymphoma (MZL). In this MZL-1 translocation, the two promoters of PAX-5 were replaced on the derivative chromosome 14 by an immunoglobulin switch Smicro promoter that was linked to the structural PAX-5 gene upstream of its translation initiation codon in exon 1B. Expression analyses confirmed that PAX-5 transcription was upregulated due to efficient initiation at the Smicro promoter in the malignant B lymphocytes of patient MZL-1. For comparison we have analyzed PAX-5 expression in another B-cell lymphoma, KIS-1, indicating that transcription from the distal PAX-5 promoter was increased in this tumor in agreement with the previously characterized translocation of the immunoglobulin Emicro; enhancer adjacent to PAX-5 exon 1A. In both lymphomas, the J-chain gene, which is thought to be under negative control by BSAP, was not expressed, whereas transcription of the putative target gene p53 was unaffected by PAX-5 overexpression. Together these data indicate that the t(9;14)(p13;q32) translocation contributes to lymphoma formation as a regulatory mutation that leads to increased PAX-5 expression in late B-cell differentiation due to promoter replacement or enhancer insertion.

journal_name

Blood

journal_title

Blood

authors

Morrison AM,Jäger U,Chott A,Schebesta M,Haas OA,Busslinger M

subject

Has Abstract

pub_date

1998-11-15 00:00:00

pages

3865-78

issue

10

eissn

0006-4971

issn

1528-0020

journal_volume

92

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Phosphotyrosine profiling identifies the KG-1 cell line as a model for the study of FGFR1 fusions in acute myeloid leukemia.

    abstract::The 8p11 myeloproliferative syndrome (EMS) is associated with translocations that disrupt the FGFR1 gene. To date, 8 fusion partners of FGFR1 have been identified. However, no primary leukemia cell lines were identified that contain any of these fusions. Here, we screened more than 40 acute myeloid leukemia cell lines...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-06-026666

    authors: Gu TL,Goss VL,Reeves C,Popova L,Nardone J,Macneill J,Walters DK,Wang Y,Rush J,Comb MJ,Druker BJ,Polakiewicz RD

    更新日期:2006-12-15 00:00:00

  • PPACK-thrombin inhibits thrombin-induced platelet aggregation and cytoplasmic acidification but does not inhibit platelet shape change.

    abstract::We have re-evaluated the previously reported ability of TLCK-thrombin (N alpha-tosyl-L-lysine chloromethyl ketone-treated alpha-thrombin) and PPACK-thrombin (D-phenylalanyl-L-prolyl-L-arginine chloromethyl ketone-treated alpha-thrombin) to inhibit alpha-thrombin-induced platelet activation (Harmon JT, Jamieson GA: J B...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Greco NJ,Tenner TE Jr,Tandon NN,Jamieson GA

    更新日期:1990-05-15 00:00:00

  • Hematopoietic progenitors and interleukin-3-dependent cell lines synthesize histamine in response to calcium ionophore.

    abstract::The calcium ionophore A23187 promotes histamine synthesis in murine bone marrow cells by increasing the expression of mRNA encoding histidine decarboxylase (HDC), the histamine-forming enzyme. The cells responsible for this biological activity copurify with hematopoietic progenitors in terms of density, light scatter ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Dy M,Arnould A,Lemoine FM,Machavoine F,Ziltener H,Schneider E

    更新日期:1996-04-15 00:00:00

  • Inflammation rapidly reorganizes mouse bone marrow B cells and their environment in conjunction with early IgM responses.

    abstract::Systemic inflammation perturbs the bone marrow environment by evicting resident B cells and favoring granulopoiesis over lymphopoiesis. Despite these conditions, a subset of marrow B cell remains to become activated and produce potent acute immunoglobulin M (IgM) responses. This discrepancy is currently unresolved and...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-03-635805

    authors: Moreau JM,Berger A,Nelles ME,Mielnik M,Furlonger C,Cen SY,Besla R,Robbins CS,Paige CJ

    更新日期:2015-09-03 00:00:00

  • Distribution of plasma membrane Ca2+ pump activity in normal human red blood cells.

    abstract::The plasma membrane calcium pump (PMCA) is the only active Ca2+ transporter in human red blood cells (RBCs). Previous measurements of maximal Ca2+ extrusion rates (Vmax) reported only mean values in the RBC population. Despite early evidence for differences in Ca2+ extrusion capacity among RBCs, the precise Vmax distr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-06-1787

    authors: Lew VL,Daw N,Perdomo D,Etzion Z,Bookchin RM,Tiffert T

    更新日期:2003-12-01 00:00:00

  • Vitamin K antagonists in children with heart disease: height and VKORC1 genotype are the main determinants of the warfarin dose requirement.

    abstract::Managing vitamin K antagonist (VKA) therapy is challenging in children because of a narrow therapeutic range and wide inter- and intra-individual variability in dose response. Only a few small studies have investigated the effect of nongenetic and genetic factors on the dose response to VKAs in children. In a cohort s...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-07-365502

    authors: Moreau C,Bajolle F,Siguret V,Lasne D,Golmard JL,Elie C,Beaune P,Cheurfi R,Bonnet D,Loriot MA

    更新日期:2012-01-19 00:00:00

  • Dasatinib treatment of chronic-phase chronic myeloid leukemia: analysis of responses according to preexisting BCR-ABL mutations.

    abstract::Dasatinib is a BCR-ABL inhibitor with 325-fold higher potency than imatinib against unmutated BCR-ABL in vitro. Imatinib failure is commonly caused by BCR-ABL mutations. Here, dasatinib efficacy was analyzed in patients recruited to phase 2/3 trials with chronic-phase chronic myeloid leukemia with or without BCR-ABL m...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-04-214221

    authors: Müller MC,Cortes JE,Kim DW,Druker BJ,Erben P,Pasquini R,Branford S,Hughes TP,Radich JP,Ploughman L,Mukhopadhyay J,Hochhaus A

    更新日期:2009-12-03 00:00:00

  • Constitutive production of leukemia differentiation, colony-stimulating, erythroid burst-promoting, and pluripoietic factors by a human hepatoma cell line: characterization of the leukemia differentiation factor.

    abstract::Conditioned medium (CM) obtained from a human hepatoma cell line, SK-HEP-1, contains colony-stimulating factors (CSFs) active on murine and human bone marrow-derived granulocyte and macrophage colony-forming units (CFU-GM) and a factor capable of inducing granulocyte-macrophage differentiation (GM-DF) of murine myelom...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gabrilove JL,Welte K,Lu L,Castro-Malaspina H,Moore MA

    更新日期:1985-08-01 00:00:00

  • Mode of action of iron (III) chelators as antimalarials: I. Membrane permeation properties and cytotoxic activity.

    abstract::We have designed two subfamilies of lipophilic iron (III) chelators previously termed reversed siderophores (RSFs). The agents display physicochemical properties that favor extraction of iron beyond membrane barriers of Plasmodium falciparum-infected red blood cells. We studied the in vitro antimalarial potency of RSF...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lytton SD,Mester B,Dayan I,Glickstein H,Libman J,Shanzer A,Cabantchik ZI

    更新日期:1993-01-01 00:00:00

  • Cytogenetic evolution patterns in non-Hodgkin's lymphoma.

    abstract::Secondary chromosomal aberrations were surveyed in non-Hodgkin's lymphomas (NHL) reported in the literature with one of the following, presently recognized, primary abnormalities: t(2;5), +3, t(3;14), del(6q), +X, and -Y. Of 2,175 NHLs with clonal karyotypic changes, 908 (42%) had one of the 13 selected primary chromo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Johansson B,Mertens F,Mitelman F

    更新日期:1995-11-15 00:00:00

  • Interleukin-9 regulates NF-kappaB activity through BCL3 gene induction.

    abstract::BCL3 encodes a protein with close homology to IkappaB proteins and interacts with p50 NF-kappaB homodimers. However, the regulation and transcriptional activity of BCL3 remain ill-defined. We observed here that interleukin-9 (IL-9) and IL-4, but not IL-2 or IL-3, transcriptionally upregulated BCL3 expression in T cell...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Richard M,Louahed J,Demoulin JB,Renauld JC

    更新日期:1999-06-15 00:00:00

  • Granulocyte-macrophage colony-stimulating factor rescues TF-1 leukemia cells from ionizing radiation-induced apoptosis through a pathway mediated by protein kinase Calpha.

    abstract::Protein kinase C (PKC) activity has a recognized role in mediating apoptosis. However, the role of individual PKC isoforms in apoptosis is poorly defined. Therefore, we investigated the translocation of individual PKC isoforms during radiation-induced apoptosis with and without rescue from apoptosis by granulocyte-mac...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kelly ML,Tang Y,Rosensweig N,Clejan S,Beckman BS

    更新日期:1998-07-15 00:00:00

  • BCR-ABL point mutants isolated from patients with imatinib mesylate-resistant chronic myeloid leukemia remain sensitive to inhibitors of the BCR-ABL chaperone heat shock protein 90.

    abstract::Clinical resistance to imatinib mesylate is commonly observed in patients with advanced Philadelphia chromosome- positive (Ph(+)) leukemias. Acquired resistance is typically associated with reactivation of BCR-ABL due to kinase domain mutations or gene amplification, indicating that BCR-ABL remains a viable target for...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-05-1361

    authors: Gorre ME,Ellwood-Yen K,Chiosis G,Rosen N,Sawyers CL

    更新日期:2002-10-15 00:00:00

  • iNKT and memory B-cell alterations in HHV-8 multicentric Castleman disease.

    abstract::Human herpesvirus 8 (HHV-8) is the causative agent of Kaposi sarcoma (KS) and multicentric Castleman disease (MCD), a life-threatening, virally induced B-cell lymphoproliferative disorder. HHV-8 is a B-lymphotropic γ-herpesvirus closely related to the Epstein-Barr virus (EBV). Invariant natural killer T (iNKT) cells a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-06-719716

    authors: Sbihi Z,Dossier A,Boutboul D,Galicier L,Parizot C,Emarre A,Hoareau B,Dupin N,Marcelin AG,Oudin A,Fieschi C,Agbalika F,Autran B,Oksenhendler E,Carcelain G

    更新日期:2017-02-16 00:00:00

  • Identification and characterization of a differentiation antigen in human neutrophils and monocytes.

    abstract::Human promyelocytic leukemia (HL-60) cells were induced to differentiate into macrophage-like cells by treatment with 10(-7) mol/L 1,25-dihydroxyvitamin D3 (VD3). A monoclonal antibody (MoAb, 60B8), reactive with the particulate of the differentiated cells but not of the untreated cells, was isolated. The antigen reco...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Nozawa R,Kato H,Ito T,Yokota T

    更新日期:1988-05-01 00:00:00

  • Distribution of dehydration rates generated by maximal Gardos-channel activation in normal and sickle red blood cells.

    abstract::The Ca(2+)-activated K+ channels of human red blood cells (RBCs) (Gardos channels, hIK1, hSK4) can mediate rapid cell dehydration, of particular relevance to the pathophysiology of sickle cell disease. Previous investigations gave widely discrepant estimates of the number of Gardos channels per RBC, from as few as 1 t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-01-0125

    authors: Lew VL,Tiffert T,Etzion Z,Perdomo D,Daw N,Macdonald L,Bookchin RM

    更新日期:2005-01-01 00:00:00

  • Soluble CD22 as a tumor marker for hairy cell leukemia.

    abstract::CD22 is an important immunotherapeutic target on B-cell malignancies, particularly hairy cell leukemia (HCL), but its soluble extracellular domain, sCD22, has not yet been reported in the blood. By immunoaffinity and enzyme-linked immunosorbent assay techniques using anti-CD22 monoclonal antibodies, we identified the ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-01-131987

    authors: Matsushita K,Margulies I,Onda M,Nagata S,Stetler-Stevenson M,Kreitman RJ

    更新日期:2008-09-15 00:00:00

  • Correction of hypercoagulability and amelioration of pulmonary arterial hypertension by chronic blood transfusion in an asplenic hemoglobin E/beta-thalassemia patient.

    abstract::Chronic transfusion of packed red blood cells, in addition to other ongoing treatment with warfarin, acetyl salicylic acid, desferrioxamine, and other supportive measures, was given to a splenectomized hemoglobin E/beta-thalassemia woman with pulmonary arterial hypertension (PHT). Serial measurements of plasma thrombi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-09-3094

    authors: Atichartakarn V,Chuncharunee S,Chandanamattha P,Likittanasombat K,Aryurachai K

    更新日期:2004-04-01 00:00:00

  • Mcl-1L cleavage is involved in TRAIL-R1- and TRAIL-R2-mediated apoptosis induced by HGS-ETR1 and HGS-ETR2 human mAbs in myeloma cells.

    abstract::We evaluated the ability of 2 human mAbs directed against TRAILR1 (HGS-ETR1) and TRAILR2 (HGS-ETR2) to kill human myeloma cells. HGS-ETR1 and HGS-ETR2 mAbs killed 15 and 9 human myeloma cell lines (HMCLs; n = 22), respectively. IL-6, the major survival and growth factor for these HMCLs, did not prevent their killing. ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-12-007971

    authors: Menoret E,Gomez-Bougie P,Geffroy-Luseau A,Daniels S,Moreau P,Le Gouill S,Harousseau JL,Bataille R,Amiot M,Pellat-Deceunynck C

    更新日期:2006-08-15 00:00:00

  • Bcl-x(L) prevents apoptosis of late-stage erythroblasts but does not mediate the antiapoptotic effect of erythropoietin.

    abstract::The long form of B-cell lymphoma-x (Bcl-x(L)), an outer mitochondrial membrane protein, has been proposed to mediate the antiapoptotic action of erythropoietin on erythroid progenitor cells and to be necessary for heme synthesis in erythroblasts. Mice with conditional knockout of Bcl-x(L) (conditional bcl-x(-/-) mice)...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-11-4344

    authors: Rhodes MM,Kopsombut P,Bondurant MC,Price JO,Koury MJ

    更新日期:2005-09-01 00:00:00

  • von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke.

    abstract::Stroke is a leading cause of death and disability. The only therapy available is recombinant tissue plasminogen activator, but side effects limit its use. Platelets play a crucial role during stroke, and the inflammatory reaction promotes neurodegeneration. von Willebrand factor (VWF), an adhesion molecule for platele...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-03-213264

    authors: Zhao BQ,Chauhan AK,Canault M,Patten IS,Yang JJ,Dockal M,Scheiflinger F,Wagner DD

    更新日期:2009-10-08 00:00:00

  • VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy.

    abstract::Hairy cell leukemia variant (HCLv) presents with high disease burden, lack of typical antigens like CD25, and poor response to standard treatments like cladribine. Occasionally, patients with classic HCL respond poorly. Clinical and molecular features of HCL and HCLv has not been compared. Rearrangements expressing im...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-01-201731

    authors: Arons E,Suntum T,Stetler-Stevenson M,Kreitman RJ

    更新日期:2009-11-19 00:00:00

  • Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells.

    abstract::NKG2D is an activation receptor that allows natural killer (NK) cells to detect diseased host cells. The engagement of NKG2D with corresponding ligand results in surface modulation of the receptor and reduced function upon subsequent receptor engagement. However, it is not clear whether in addition to modulation the N...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-03-0918

    authors: Coudert JD,Zimmer J,Tomasello E,Cebecauer M,Colonna M,Vivier E,Held W

    更新日期:2005-09-01 00:00:00

  • Adaptive response of iron absorption to anemia, increased erythropoiesis, iron deficiency, and iron loading in beta2-microglobulin knockout mice.

    abstract::Recently, a novel gene of the major histocompatibility complex (MHC) class I family, HFE (HLA-H), has been found to be mutated in a large proportion of hereditary hemochromatosis (HH) patients. Further support for a causative role of HFE in this disease comes from the observation that beta2-microglobulin knockout (bet...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Santos M,Clevers H,de Sousa M,Marx JJ

    更新日期:1998-04-15 00:00:00

  • Beyond Hox: the role of ParaHox genes in normal and malignant hematopoiesis.

    abstract::During the past decade it was recognized that homeobox gene families such as the clustered Hox genes play pivotal roles both in normal and malignant hematopoiesis. More recently, similar roles have also become apparent for members of the ParaHox gene cluster, evolutionarily closely related to the Hox gene cluster. Thi...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2012-02-385898

    authors: Rawat VP,Humphries RK,Buske C

    更新日期:2012-07-19 00:00:00

  • A murine stromal cell line allows the proliferation of very primitive human CD34++/CD38- progenitor cells in long-term cultures and semisolid assays.

    abstract::Analysis of molecular mechanisms associated with stem cell commitment and differentiation requires an in vitro assay that identifies the most primitive hematopoietic stem cells in human bone marrow. Such primitive stem cells usually do not form colonies in short-term semisolid assays and are best identified by their a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Issaad C,Croisille L,Katz A,Vainchenker W,Coulombel L

    更新日期:1993-06-01 00:00:00

  • In vivo stem cell function of interleukin-3-induced blast cells.

    abstract::The treatment of mice with high doses of 5-fluorouracil (5-FU) results in an enrichment of primitive hematopoietic progenitors. Using this procedure, we obtained a new class of murine hematopoietic colonies that had very high secondary plating efficiencies in vitro and could differentiate into not only myeloid cells b...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Tsunoda J,Okada S,Suda J,Nagayoshi K,Nakauchi H,Hatake K,Miura Y,Suda T

    更新日期:1991-07-15 00:00:00

  • A case-control study to assess the risk of immune thrombocytopenia associated with vaccines.

    abstract::The cause of immune thrombocytopenia (ITP) remains unknown. Studies have suggested immunizations as possible triggering factors of ITP through molecular mimicry. This case-control study explored potential associations between adult ITP and various routinely administered vaccines. A network of internal medicine and hem...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1182/blood-2012-05-431098

    authors: Grimaldi-Bensouda L,Michel M,Aubrun E,Leighton P,Viallard JF,Adoue D,Magy-Bertrand N,Tisserand G,Khellaf M,Durand JM,Quittet P,Fain O,Bonnotte B,Morin AS,Limal N,Costedoat-Chalumeau N,Morel N,Pan-Petesch B,Decaux O,

    更新日期:2012-12-13 00:00:00

  • Combination of 4Ts score and PF4/H-PaGIA for diagnosis and management of heparin-induced thrombocytopenia: prospective cohort study.

    abstract::Rapid exclusion of heparin-induced thrombocytopenia (HIT) is needed to determine which patients can continue to receive heparin. In this prospective management study, 526 participants had a 4Ts score, rapid particle gel immunoassay (platelet factor 4/heparin [PF4/H]-PaGIA), and serotonin-release assay (SRA) performed....

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2014-12-618165

    authors: Linkins LA,Bates SM,Lee AY,Heddle NM,Wang G,Warkentin TE

    更新日期:2015-07-30 00:00:00

  • Vascular endothelial growth factor-A induces plaque expansion in ApoE knock-out mice by promoting de novo leukocyte recruitment.

    abstract::Vascular endothelial growth factor-A is widely used in clinical trials for the treatment of cardiac ischemia. VEGF-A was recently suggested to act in a proinflammatory manner, which could aggravate adjacent atherogenesis in VEGF-A-based therapy. To assess potential bystander effects, VEGF-A was focally overexpressed i...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-07-031773

    authors: Lucerna M,Zernecke A,de Nooijer R,de Jager SC,Bot I,van der Lans C,Kholova I,Liehn EA,van Berkel TJ,Yla-Herttuala S,Weber C,Biessen EA

    更新日期:2007-01-01 00:00:00